Danna nan don nuna banners ɗin ku akan wannan shafin kuma ku biya kawai don nasara

Labaran Waya

Sabuwar Yarda da Magunguna don Maganin Kumburi da Ciwo

Written by edita

AffaMed Therapeutics a yau ta sanar da cewa an amince da DEXTENZA a Macau na kasar Sin don maganin kumburin ido da jin zafi bayan tiyatar ido. A cikin 2020, AffaMed Therapeutics ya shiga yarjejeniyar lasisi tare da Ocular Therapeutix don haɓakawa da kasuwancin DEXTENZA a cikin Babban China, Koriya ta Kudu, da wasu kasuwannin ASEAN. DEXTENZA a halin yanzu an amince da ita a Amurka don maganin kumburin ido da zafi bayan tiyatar ido da kuma maganin itching na ido hade da rashin lafiyar conjunctivitis.

Dokta Dayao Zhao, Shugaba na AffaMed ya yi sharhi: “An ƙarfafa mu da manufofin gwamnatin Macau da kuma yadda ya dace wajen yin rajistar sabbin hanyoyin kwantar da hankali bisa ga ƙwaƙƙwaran gwajin gwaji na asibiti daga gwajin rajistar FDA na Ocular. Ƙungiyarmu tana shirya aikace-aikace don faɗaɗa alamar da aka yarda don haɗawa da maganin itching na ido hade da rashin lafiyar conjunctivitis. Muna fatan ƙaddamar da DEXTENZA da samar da samfurin ga marasa lafiya a Macau da wuri-wuri. "

Ta hanyar karɓar wannan amincewa, DEXTENZA ta zama farkon ci gaba mai dorewa-saki na ciki na ciki a Macau yana isar da kashi na dexamethasone marar adanawa har zuwa kwanaki 30 tare da gudanarwa ɗaya.

Shafin Farko

Game da marubucin

edita

Edita a shugaba na eTurboNew ita ce Linda Hohnholz. Ta dogara ne a HQ eTN a Honolulu, Hawaii.

Leave a Comment

Share zuwa...